TNF and rheumatoid arthritis: A relapse after an initial response to TNF-a antagonist therapy may indicate either drug-induced granulomatous disease or the development of antidrug antibodies, as reported with infliximab or adalimumab in patients with rheumatoid arthritis (139, 140).